The impact of the COVID-19 pandemic on global trade-embodied carbon emissions

Advancing Sustainable Fluorine Management in China Based on Evolution of the Anthropogenic Cycle during 2000-2020

Fluorine (F) has substantial social and environmental significance. Despite its high natural abundance, which often leads to the neglect of its sustainable management, its primary source, fluorspar, is limited and nonrenewable. As the world's largest producer and consumer of F resources, China encounters considerable challenges in managing these resources sustainably. However, a comprehensive understanding of F flows across China's economy has been notably absent. This study establishes a national-level material flow analysis (MFA) framework to examine the circulation and accumulation of F substances across various sectors in China from 2000 to 2020. The MFA encompasses over 200 F-containing products and 15 key sectors, tracking F flows through the stages of production, manufacturing, use, and waste management. Key findings show that China's F resource supply increased from 2297.9 kt in 2000 to 6392.2 kt in 2020, with 91.1% sourced from domestic ore mining. F consumption for manufacturing F-containing products rose from 270.1 to 2462.9 kt over the same period. Traditional sectors like metallurgy, cement production, and electrolytic aluminum dominated F consumption, while emerging sectors like photovoltaics experienced rapid growth. China has been a net exporter of F resources, with exports totaling 14,732.3 kt compared to 1931.1 kt of imports over the two decades. Nonetheless, China's role in global F trade has shifted from primarily exporting ores to becoming a major producer and exporter of F-containing products. This study provides a comprehensive analysis to date of China's F resource flows, offering critical insights for policymakers and industry stakeholders to enhance sustainable F management practices and address key challenges related to resource supply, utilization efficiency, and environmental impacts.

Ship emission variations during the COVID-19 from global and continental perspectives

The COVID-19 pandemic and the International Maritime Organization's (IMO) 2020 fuel-switching policy have profoundly impacted global maritime activities, leading to unprecedented changes in shipping emissions. This study aimed to examine the effects from different scales and investigate the underlying drivers. The big data model Ship Emission Inventory Model (SEIM) was updated and applied to analyze the spatiotemporal pattern of global ship emissions as well as the main contributors in 2019 and 2020. Overall, ships emitted NOx, CO, HC, CO2, and N2O declined by 7.4 %-13.8 %, while SO2, PM2.5, and BC declined by 40.9 %-81.9 % in 2020 compared with 2019. The decline in CO2 emissions indicated a comparable reduction across vessel tonnages. Ship emissions occurring at cruising status accounted for over 90 % of the ship's CO2 emission reduction. Container ships, chemical tankers, and Ro-Ro vessels were the primary contributors to the emission reductions, with container ships alone responsible for 39.4 % of the CO2 decrease. The ship's CO2 emissions variations revealed the decline-rebound patterns in response to the pandemic. Asian-related routes saw emissions drop in February 2020, followed by a rebound in May, while European and American routes experienced declines starting in May, with a recovery in August. Further analysis of CO2 emission in Exclusive Economic Zones (EEZs) showed high temporal consistency between vessel CO2 emissions, sailing speeds, and international trade volumes across continents, and exhibited heterogeneity in main contributing ship type of emission reduction on continental scale. Our study reveals the short-term fluctuation characteristics of global ship emissions during the pandemic, particularly focusing on their spatiotemporal evolution and the inherent disparities. The results highlight the correlation between global ship emissions and trade, as well as the operational status of ships, and their rigidity.

Deep mitigation for trade-embodied carbon emissions among the Belt and Road Initiative countries

The frequent trade within and beyond the Belt and Road Initiative (BRI) has prospered the economy but has also expanded carbon emissions. Here, through a multi-regional environmental input-output analysis framework, we explore the patterns and inter-sectoral linkage of trade-embodied carbon emissions among BRI countries during 2015-2019. Then, a dynamic data envelopment analysis model considering carbon inequality as a non-discretionary input is constructed to assess the carbon emission efficiency of the identified key sector. We find that trade-embodied carbon emissions in the BRI steadily increased during 2015-2019. The manufacturing sector was identified as the key sector, exhibiting an overall efficiency of 0.6268 on average, with significant efficiency disparities. Moreover, we validate the positive role of efficiency enhancement in carbon emission mitigation, as well as the negative moderating effect of carbon inequality. Overall, this study provides optimal collaboration and initiatives to mitigate trade-embodied carbon emissions among BRI countries deeply.

The economic consequence of large-scale epidemic outbreak: The path and loss evaluation of COVID-19 in China based on input-output analysis

The COVID-19 pandemic has significantly impacted China's economic and social development. Understanding the direct and indirect effects of the epidemic on the economy is vital for formulating scientifically grounded epidemic management policies. This study assesses the economic losses and influence paths of a large-scale epidemic in China. We proposed three COVID-19 scenarios - serious, normal, and mild - to evaluate the direct economic impact on China's GDP from a demand perspective. An input-output model was used to estimate the indirect impact. Our findings show that China's GDP could lose 94,206, 75,365, and 56,524 hundred million yuan under serious, normal, and mild scenarios, respectively, with corresponding GDP decline rates of 9.27%, 7.42%, and 5.56%. Under the normal scenario, indirect economic loss and total loss are projected at 75,364 and 489,386 hundred million yuan, respectively. Additionally, the pandemic led to a reduction in carbon emissions: direct emissions decreased by 1,218.69 million tons, indirect emissions by 9,594.32 million tons, and total emissions by 10,813.01 million tons across various industries. This study provides a comprehensive analysis of the economic and environmental impacts of the pandemic.

Advancement of Computational Design Drug Delivery System in COVID-19: Current Updates and Future Crosstalk- A Critical update

Positive strides have been achieved in developing vaccines to combat the coronavirus-2019 infection (COVID-19) pandemic. Still, the outline of variations, particularly the most current delta divergent, has posed significant health encounters for people. Therefore, developing strong treatment strategies, such as an anti-COVID-19 medicine plan, may help deal with the pandemic more effectively. During the COVID-19 pandemic, some drug design techniques were effectively used to develop and substantiate relevant critical medications. Extensive research, both experimental and computational, has been dedicated to comprehending and characterizing the devastating COVID-19 disease. The urgency of the situation has led to the publication of over 130,000 COVID-19-related research papers in peer-reviewed journals and preprint servers. A significant focus of these efforts has been the identification of novel drug candidates and the repurposing of existing drugs to combat the virus. Many projects have utilized computational or computer-aided approaches to facilitate their studies. In this overview, we will explore the key computational methods and their applications in the discovery of small-molecule therapeutics for COVID-19, as reported in the research literature. We believe that the true effectiveness of computational tools lies in their ability to provide actionable and experimentally testable hypotheses, which in turn facilitate the discovery of new drugs and combinations thereof. Additionally, we recognize that open science and the rapid sharing of research findings are vital in expediting the development of much-needed therapeutics for COVID-19.